The team

Our team of experts

From the pharmaceutical industry, agriculture and business

The MediCrops® team


Ivan Mestrangelo
Chief Executive Officer

Entrepreneur with several years of experience in the establishment and management of companies in the construction/contracting, catering, raw materials and pharmaceutical sectors. To translate a vision step by step into reality, develop a business in accordance with his own ideas from the initial ground-breaking onward and allow it to flourish like a plant – that’s the elixir of life upon which Ivan Mestrangelo thrives.


Luitpold Wüsthof
Chief Financial Officer

Degree in business studies, a Master of Arts in philosophy, politics and economics from LMU Munich and GE Lean Six Sigma Green Belt certified. Many years of experience in strategic planning, finance and financial communication in listed multinational companies (General Electric, OC Oerlikon, Von Roll).


Gregory Schaeffer
Chief Technology Officer & Quality Director

Gregory Schaeffer studied chemical engineering and brings over 15 years of experience from the pharmaceutical industry & medical technology sector (Novartis, Roche, Celgene, Johnson & Johnson). He is also chairman of the Swiss Safe Access for Cannabinoids Association. He has in-depth knowledge of the production of APIs (active pharmaceutical ingredients), quality control and quality assurance according to EU GMP guidelines.


Sascha Tanner
Plant Tissue Culture Expert

Sascha Tanner is an internationally recognised plant and tissue culture expert. He brings many years of experience from commercial plant breeding with medicinal cannabis. From the very start he has held a key position in the management of plant breeding.


Dr. Patrick Buschor
Qualified Person, Quality Management System Consultant (PMS System)

Patrick Buschor completed his doctorate at the Institute of Immunology at the University of Bern in 2014. and brings a broad range of experience to the MediCrops team.


Maria-Luisa Musumeci
Assistant to the Management

Many years of experience in the administrative and commercial support of the Executive Board and the Investor Relations department.

Advisory Board


Toby Shillito

Globally leading expert in commercial cultivation in accordance with the most stringent standards. Toby Shillito has completed a whole range of Master’s degrees in the areas of management, corporate finance & responsibility and strategic business development. He is a recognised expert and prominent lecturer at international conventions.


Prof. Dr. Felix Niggli

Head of the Oncology Department at the Children’s Hospital Zurich and well-known oncologist, who practices his profession with enormous passion. Felix Niggli has been in retirement since the start of 2020. He supports the MediCrops® group of companies in research and networking with other doctors.

For prospective investors

Medical THC is one of the markets of the future in the pharmaceutical sector and MediCrops® covers the entire value chain, from cultivation to finished processing. Strarting from CHF 50,000 investors can participate in the growth of MediCrops®. Detailed information can be found in the comprehensive documentation.